COVID Vaccine Manufacturer Ordered to Pay $263 Million for Role in Largest Overdose Epidemic in History

By Matt Agorist | The Free Thought Project

Despite the state spending thousands of dollars a second – ticketing, kidnapping, caging, and killing evil drug users, the rate of lethal drug overdoses in the last 15 years has skyrocketed at near-exponential rates. According to the most recent data on overdose deaths, despite the state’s immoral war on drugs, the Centers for Disease Control and Prevention estimates that more than 92,000 Americans died of an overdose in the 12-month span ending in November — the highest number ever recorded. To understand how we got to this point, we have to look at how Americans became so addicted to opioids. Spoiler alert, it was not by chance.

Across the board, drug use and deaths associated with drug use have increased at alarming rates. No amount of AR-15s, SWAT police, MRAPs, or any other military gear has had a hand in lowering these statistics. In fact, the increase in overdose deaths nearly perfectly coincides with the increase in militarization of police in the last decade and a half.

Instead of deterring drug use, it’s been expanding, getting worse, and drugs have become more available and more dangerous. How did this happen?

There are legitimate needs for opioids just like there are legitimate needs for cannabis. But when people are taught their entire lives to blindly trust the medical industry, who clearly choose to deceive them, we end up with problems like we have today.

The government making drugs illegal does absolutely nothing when a person puts blind trust in a medical establishment who then deliberately addicts them to opioids to make billions. Even when it’s illegal, after these people have been duped into their addictions, they still seek it out. This is why we see soccer moms overdosing on dangerous black market fentanyl in front of Hobby Lobby.

They put blind trust in the government and medical industry to protect them and instead were turned out for a buck.

Drug manufacturers deliberately deceived patients and doctors about the risks of opioids, pushed prescribers to keep patients on the drugs longer, and aggressively targeted vulnerable populations, such as the elderly and veterans.

One such company was Johnson & Johnson, which was ordered this week to pay $263 million to resolve claims it fueled an opioid epidemic in New York state and two of its largest counties.

“The opioid epidemic has wreaked havoc” across the nation, New York Attorney General Letitia James said in a statement. “Johnson & Johnson helped fuel this fire.”

Indeed, they did. According to the original $465 million lawsuits out of Oklahoma, J&J deliberately deceived doctors and patients about their opioid drugs which played a major role in the deaths of hundreds of thousands of Americans. Yes, hundreds of thousands. According to the CDC, nearly 500,000 people died from opioid overdoses from 1999 to 2019.

Given J&J’s history is fueling the opioid crisis, one would be naturally skeptical of blindly receiving a vaccine developed by the same company in record time. What’s more, while the opioid crisis is bad enough J&J’s past is far more insidious than just opioids.

Johnson & Johnson also knew for decades their baby powder was tainted with carcinogenic asbestos and they kept that information from regulators and the public. A government-funded study from the mid-1990s found that Johnson’s baby powder caused cancer in rats and other studies have found an increased risk of cancer in women who used their talc-based products. The potential risks have been known to the company for decades.freestar

What’s more, in 2018, the pharma giant was ordered to pay $4.7 billion to thousands of victims who reportedly developed cancer from using Johnson & Johnson’s products. In that case, 22 women alleged the company’s talc-based products, including its baby powder, contained the known carcinogen, asbestos, which caused them to develop cancer. According to reports, there are over 9,000 similar talc lawsuits against the company.

Currently faced with several major lawsuits for fueling the opioid crisis in the United States, Johnson & Johnson also has a history of bribing doctors and government officials. Even more disturbing still, a Reuters investigation found that J&J knowingly sold a baby powder product that they knew had asbestos in it, which causes mesothelioma.

When this information is brought up, those who report on it are fact-checked into oblivion. In April, we discovered that these companies are actually tied to the fact-checkers, providing a possible reason for such massive censorship.

According to their own source, Factcheck.org is funded in part by the Robert Wood Johnson Foundation. According to the foundation’s 2019 financial statement, the project holds over $1.8 billion of stock in the COVID-19 manufacturer, Johnson & Johnson.

To be clear, no one here is claiming that these vaccines will hurt massive amounts of people or that they will not be beneficial in stopping the virus. No one here at TFTP is telling anyone what to do in regard to vaccinations. We are, however, advocating for safety at all levels of this process. Nevertheless, those who promote vaccine safety are increasingly being treated as outcasts and lawmakers and media alike are calling for them to be silenced.

Skepticism is not dangerous, as the media would have you believe. It is necessary for producing a safe product yet Johnson & Johnson has a highly questionable history of operating procedures that are the antithesis of safety. It’s not just J&J either.

In 2000 the Washington Post published a major exposé accusing Pfizer of testing a dangerous new antibiotic called Trovan on children in Nigeria without receiving proper consent from their parents. The experiment occurred during a 1996 meningitis epidemic in the country. In 2001 Pfizer was sued in U.S. federal court by thirty Nigerian families, who accused the company of using their children as human guinea pigs.

Now, the Washington Post is defending the same company in regards to the vaccination.

The pharmaceutical giant also paid out $2.3 billion in 2009 to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products.

“Pfizer violated the law over an extensive-time period. Furthermore, at the very same time, Pfizer was in our office negotiating and resolving the allegations of criminal conduct by its then newly acquired subsidiary, Warner-Lambert, Pfizer was itself in its other operations violating those very same laws,” Mike Loucks, acting U.S. Attorney for the District of Massachusetts said at the time.

But that was only a single case, this company has a track record dating back decades that includes everything from bribing government officials to illegally testing products on children to making false claims about drugs and illegally marketing them — leading to multiple deaths. Despite making the largest payout in history, Pfizer has continued to be called to the carpet since 2009 multiple times for misleading the public about their drugs — up to and including vaccines.

If we applied the “three-strike” rule to these companies as we do to individuals, they would be in prison for life. Instead, they are receiving tens of billions in taxpayer dollars to help push their fast-tracked vaccines on Americans.

Are we supposed to forget the track record of these companies who deliberately misled regulators about the hazards of their products, knowingly contributing to the deaths of more than 125 people? Or who experimented on children? Or who has paid out hundreds of millions in settlements for the deaths of scores of patients?

The fact is that these companies have track records that include bribing government officials to illegally testing products on children to making false claims about drugs and illegally marketing them.

The ability of Americans to forget the pasts of these companies and blindly line up for a jab that has set off a historical number of adverse reaction reports to the CDC’s VAERS database is uncanny. Yet those who question it are silenced. This is the state of “science” in the modern world.

About the Author

Matt Agorist is an honorably discharged veteran of the USMC and former intelligence operator directly tasked by the NSA. This prior experience gives him unique insight into the world of government corruption and the American police state. Agorist has been an independent journalist for over a decade and has been featured on mainstream networks around the world. Agorist is also the Editor at Large at the Free Thought Project. Follow @MattAgorist on TwitterSteemit, and now on Minds.

Media Hails New J&J Vaccine, Ignores Pharma Giant’s ‘Checkered Past’

By Children’s Health Defense Team | The Defender

On Feb. 26, the U.S. Food and Drug Administration (FDA) announced — via a Saturday evening tweet — that the agency granted Emergency Use Authorization for Johnson & Johnson’s (J&J) coronavirus vaccine for Americans 18 and older.

Claiming that “we’re in a hurry” because there’s not enough supply of the two COVID-19 vaccines already authorized for emergency use — Pfizer’s and Moderna’s — members of FDA’s committee agreed without dissent to allow a third COVID injection into the U.S. mix.

While the media drummed up enthusiasm for the expanded options, the Washington Post on March 2 offered an even splashier scoop: a “historic” production partnership between J&J and Merck, two pharma giants ordinarily portrayed as “fierce competitors.”

Employing hyperbolic language about the “wartime effort” and good “corporate citizenship,” public health leaders instantly celebrated the “unusual” arrangement for its potential to double “what Johnson & Johnson could make on its own.”

Experts bill J&J’s one-dose injections, which are storable for several months at refrigerator temperatures, as the ideal solution for vaccine programs challenged by the trickier storage and handling requirements of the two-dose Pfizer and Moderna shots — an “advantage [that] goes up in neon,” Dr. William Schaffner, an internist and infectious disease specialist with Vanderbilt University’s Department of Health Policy, told News7 Boston.

Dr. Nancy Messonnier, who leads the Centers for Disease Control and Prevention’s (CDC) COVID-19 vaccine efforts — and who two years ago sat next to Dr. Anthony Fauci as he gave Congress false information about adverse events from measles vaccination — according to CNBC conceded the J&J product will be “operationally easier in lots of contexts” and “better suited for some populations.”

Anticipating a lucrative opportunity, J&J is already preparing to launch expanded clinical trials in children (including newborns and infants) and pregnant women.

Different design, same goal

Rather than use the messenger RNA (mRNA) technology being deployed for the first time in the Pfizer and Moderna injections, J&J’s vaccine (made by the company’s Janssen Pharmaceuticals subsidiary) features a genetically engineered “viral vector” design reliant on a weakened common-cold virus called adenovirus 26.

Adenovirus vaccines have a lengthy history of use in the U.S. military, but the FDA’s emergency green light for J&J’s COVID injection represents the first time the agency has authorized an adenovirus-vectored vaccine for civilian use.

Last summer, J&J obtained European approval for an Ebola vaccine using vector technology. Oxford-AstraZeneca and CanSino Biologics have adopted a similar approach for their COVID-19 vaccines, though with different adenoviral vectors.

As J&J describes them, adenoviruses are “good for transporting things into humans.” In the case of the COVID vaccine, the aim is to shuttle genetic instructions — DNA coding for the coronavirus spike protein — into the cells and force the cells to make spike protein. In theory, these “self-made spike proteins” are then supposed to train the body to “detect and terminate any real SARS-CoV-2 infections before the virus wreaks havoc.”

Although the mode of delivery is different from the lipid nanoparticles (what CNN describes as “delicate little balls of fat”) that function as a carrier system for the Pfizer and Moderna mRNA vaccines, all three FDA-authorized COVID vaccines share the same novel goal of getting the body to manufacture spike protein — a goal that represents a radical departure from traditional vaccines.

A University of Tennessee microbiologist told Knox News that J&J’s approach is immunologically powerful, stating that the modified adenovirus vector is “about as subtle as a wrecking ball” and “very visible to the immune system.”

According to a May 2020 article in Chemical & Engineering News, the adenovirus approach — with 30 years of study behind it — has a “checkered past,” including as a “failed gene therapy.”

Undaunted by adenoviral vectors’ ability to generate dramatic and even fatal inflammatory effects, vaccine researchers embraced the strategy, only to discover that booster shots might “unleash an antibody attack on the vaccine itself.”

In 2007, Merck encountered yet another problem when it conducted clinical trials for an adenoviral-vectored HIV vaccine that, paradoxically, increased the risk of HIV infection in a subset of recipients — a cautionary tale that “put a big kibosh on adenoviruses” for some years thereafter.

‘Morally compromised’

In response to the FDA’s emergency authorization of J&J’s COVID-19 vaccine, the Catholic Archdiocese of New Orleans and Catholic leaders in St. Louis immediately pronounced the injection “morally compromised,” citing the company’s “extensive use of abortion-derived cell lines” and urging local Catholics not to take it. These objections are in the same vein as a letter submitted to the FDA a year ago by the U.S. Conference of Catholic Bishops, which expressed concern about the development of COVID-19 vaccines reliant on “ethically problematic” cell lines.

The cell line in which Janssen grows its adenovirus vector is a human embryonic cell line called PER.C6. The retinal tissue that launched the cell line was obtained following the elective abortion of a healthy, 18-week-old fetus. The AstraZeneca-Oxford COVID vaccine uses a different human embryonic cell line called HEK293T to propagate its adenovirus.

To produce a continuous cell line of this type — what is called an “immortalized” cell line — scientists must artificially manipulate the original cells, which otherwise would have finite lifespans. This is accomplished by introducing chemical exposures or rendering them cancerous. Because this manipulation introduces genetic changes into the cells, “cell populations and cellular mechanisms are altered.”

A senior FDA official warned over two decades ago about the inherent risks of using continuous cell lines for vaccine development, noting that such cell lines, “by definition” have abnormalities, and worriedly acknowledging their “potential for growing tumors in laboratory animals.”

An FDA document published in late 2020 shows that these issues are far from resolved; explicitly referring to cell lines such as PER.C6 and HEK293T, the FDA author states: “The use of tumorigenic and tumor-derived cells is a major safety concern” and observes that the cell lines contain “latent” or “quiet” threats that “might become active under vaccine manufacturing conditions.”

The fact sheet for healthcare providers administering the J&J COVID vaccine specifies that each dose of vaccine “may … contain residual amounts of host cell proteins … and/or host cell DNA,” but the simplified fact sheet intended for vaccine recipients and their caregivers does not.

That means that unless vaccine recipients seek out the healthcare provider fact sheet, they’ll be unaware of this potentially crucial piece of information.

The Italian vaccine research and advocacy organization, Corvelva, which has conducted detailed studies of DNA from aborted fetal cell lines in vaccines, warns that such DNA is abnormal and potentially tumor-causing. Corvelva concludes that vaccines of this type “should be considered defective and potentially dangerous to human health.”

Along with a variety of other inactive ingredients, the J&J COVID vaccine also includes polysorbate-80, a stabilizer that studies have shown capable of transporting other substances across the blood-brain barrier.

Serial felons

When evaluating the potential safety of the J&J-plus-Merck experimental COVID vaccine, it would be prudent to take note of the corporate behemoths’ less-than-flattering track records as serial felons.

Merck, for example, paid out $4.85 billion in 2007 after pleading guilty to criminal charges over illegal marketing of its lethal drug Vioxx. The company has gone on to face numerous other allegations of fraud, deceit, and negligence, including for its measles, mumps, and rubella (MMR) and human papillomavirus (HPV) vaccines.

For its part, J&J’s recent criminal history includes:

  • A 2013 order by the U.S. Department of Justice to pay $2.2 billion in civil and criminal fines related to the antipsychotic drug Risperdal and two other drugs, following aggressive off-label marketing and other dubious practices such as fraud and kickbacks.
  • A 2019 award by a Philadelphia jury of $8 billion in punitive damages to a man alleging that J&J failed to warn that Risperdal could lead to breast growth in boys. Thousands of other lawsuits against J&J feature the same allegation.
  • $572 million judgment against J&J by the state of Oklahoma in 2019 for the company’s role in the opioid crisis.
  • $3.9 billion set aside for 25,000 lawsuits related to J&J’s asbestos-tainted baby powder. And a 2018 Missouri verdict, “one of the largest punitive-damages awards in U.S. legal history,” was reached after internal documents showed that the company had been aware of the baby powder contamination since the 1970s.

In the wake of these scandals, The Guardian wrote in 2019 that “experts are concerned that one of the world’s most recognizable names and most reliable and valuable companies is caught in no less than an existential crisis.” Citing the “product misfires,” “court judgments” and stark reputational decline, the British news outlet asked, “what happened to Johnson & Johnson?”

With the advent of J&J’s COVID vaccine (an injection already being hawked as a “vaccine for the world” and the potential “end of the pandemic”), it appears that The Guardian has its answer: J&J will send its former woes down the memory hole, an obliging media will ignore the spotty safety record of past adenovirus vaccine attempts (including J&J’s paused clinical trial last October) and a to-be-determined number of COVID-frightened Americans — tempted by the ease of a single shot — will line up for J&J’s investigational injection that, in the FDA’s own words, is “not licensed for any indication.”

Sadly, many of these individuals will be unaware that, unlike with dangerous drugs, they cannot sue indemnified COVID vaccine manufacturers should anything go wrong.

Johnson & Johnson Pauses COVID Vaccine Trials After ‘Unexplained Illness’

By Jeremy Loffredo | Children’s Health Defense

Johnson & Johnson temporarily paused Phase 3 clinical trials of its COVID-19 vaccine on Monday after one participant experienced what the company termed “an unexplained illness.”

The multinational maker of packaged consumer goods, medical devices and pharmaceuticals declined to provide details about the reaction or illness, leaving the public and thousands of other trial participants in the dark.

In a press release, the company said its decision to withhold details was made out of respect for the trial participant’s privacy. But the company also said the illness “might be related to a vaccine.”

According to Johnson & Johnson’s clinical trial guidelines, trials are paused only if participants experience a vaccine-related adverse event. The Phase 3 study began on Sept. 23 with researchers planning to enroll 60,000 participants in the U.S. and other countries.

Moreover, the Johnson & Johnson trial uses a sodium chloride solution (saline) as a placebo. Saline injections, regarded by the scientific community as harmless, are widely accepted as a valid placebo control in vaccine trials.

In September, the director of the National Institutes for Health, Francis Collins, told reporters that vaccine trials taking place as part of “Operation Warp Speed” are larger and more rigorous than ever before.

Yet the Johnson & Johnson trial doesn’t include any pregnant women, which makes it impossible to know if the vaccine being developed by the company might harm them or their children. All female trial participants of “childbearing potential” are required to practice “an acceptable effective method of contraception” until three months after getting the experimental vaccine.

The Data and Safety Monitoring Board, made up of a group of scientists and biostatisticians whose identities aren’t publicly known, will investigate and decide whether or not the Johnson & Johnson trials can continue.

The U.S. government already has a deal with Johnson & Johnson to buy 100 million doses of its experimental vaccine for $1 billion.

This isn’t the first time in recent history that Johnson & Johnson has faced public scrutiny regarding the safety of its products. In July 2018, a St. Louis jury awarded nearly $4.7 billion in damages to 22 women and their families who claimed the carcinogenic asbestos in Johnson & Johnson talcum powder caused their ovarian cancer. Earlier this month, Johnson & Johnson agreed to pay more than $100 million to resolve more than 1,000 lawsuits blaming its baby powder for causing cancer.

But the company won’t face a similar fate if it brings to market a COVID-19 vaccine that subsequently is found to cause illness or injuries. That’s because in March 2020, the U.S. Department of Health and Human Services issued a declaration under the Public Readiness and Emergency Preparedness Act or PREP Act that provides immunity “against any claim of loss caused by, arising out of, relating to, or resulting from the manufacture, distribution, administration, or use of medical countermeasures,” including vaccines.

The declaration indemnifies Johnson & Johnson and other vaccine makers against lawsuits, regardless of whether their new vaccines produce harmful effects.

Johnson & Johnson is the third “Operation Warp Speed” participant to report possible adverse reactions. In May, Moderna’s vaccine was shown to have a 20% “serious” injury rate in its high-dose group — one participant in the Moderna trial said he became “the sickest in his life” after taking the vaccine.

In September, AstraZeneca paused its vaccine trial after a participant suffered symptoms consistent with transverse myelitis, a neurological disorder that can result in weakness of the limbs, problems emptying the bladder and paralysis.

AstraZeneca has since resumed clinical trials in the UK, Brazil, India and South Africa. But the trials remain on hold in the U.S.

Jeremy Loffredo is a reporter for Children’s Health Defense.

Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. CHD is implementing many strategies, including legal, in an effort to defend the health of our children and obtain justice for those already injured. Your support is essential to CHD’s successful mission.

Fed’s Chosen Coronavirus Vaccine Producer has Billions in Court Penalties, no Vax Development Experience

By John Gilmore | Sarasota For Vaccination Choice

The company selected by the federal government to fast-track develop a coronavirus vaccine is the subject of billions in court settlements and judgments, in the last year alone, for being a key operator in the opioid epidemic among other criminal activities, and it has no track record in creating or manufacturing vaccines. And the federal agency that issued the contract is part of the same federal department that will oversee every aspect of the vaccine’s evaluation, licensing, and distribution.

Johnson and Johnson (J&J), and it subsidiary Janssen Pharmaceutica, the enormous global medical products firm, was awarded a $450 million contract on Monday by the US federal government. [see: https://www.forbes.com/sites/thomasbrewster/2020/03/30/the-us-just-signed-a-450-million-coronavirus-vaccine-contract-with-johnson–johnson/#43e6c87c2946 ]

J&J will be committing its own resources to bring the total value of the project to more than $1 billion. Trials of the vaccine are expected to begin in September and production for general use is expected to begin in early 2021. Normally testing and safety analysis of a new vaccine in the US takes 5 to 7 years. J&J will build a new vaccine factory in the US with a goal of producing a billion doses annually beginning next year. Yet no vaccine licensed for use in the US was developed or is manufactured by J&J. And the federal government is already assuming that the vaccine will be safe and effective.

Expedited development of vaccines in the US has a poor track record. In 1976 a vaccine was quickly brought to market for an outbreak of swine flu but just as quickly withdrawn when multiple cases of Guillain Barre Syndrome were caused. And the H1N1 virus rushed to market in 2009 also caused significant numbers of Guillain Barre Syndrome among other side effects.

It is hard to imagine any company could be facing more lawsuits than J&J. According to the Wall Street journal J&J had 103,000 legal claims by companies, individuals, states, cities, counties and other legal entities in the middle of last year. [see https://www.wsj.com/articles/johnson-johnsons-legal-challenges-mount-11571055242 ] J&J have had legal judgments and settlements of more than $10 billion just in the previous two years.

Last fall an Oklahoma Court fined J&J $465 million for its role in the opioid epidemic in that state. Judge Thad Balkman said J&J had promulgated “false, misleading, and dangerous marketing campaigns” that had “caused exponentially increasing rates of addiction, overdose, deaths” and babies born exposed to opioids. J&J also agreed to a $20 million settlement for damages associated with opioids in two Ohio counties. Thousands of other suits are pending across the US.

J&J was a major player contracting with poppy growers in Australia to supply 60% of the opiate ingredients used for drugs like oxycodone. It also produced an opioid pill the company sold in 2015, and Duragesic, a fentanyl patch.

In a statement released with the announcement of a lawsuit in the spring of 2019 against J&J and other opioid manufacturers, New York Attorney General Leticia James said, “We found that pharmaceutical manufacturers and distributors engaged in years of deceptive marketing about the risks of opioids and failed to exercise their basic duty to report suspicious behavior, leading to the crisis we are living with today.”

J&J’s legal problems go far beyond opioids. Last month a New Jersey court ordered J&J to pay $186 million in four cases where plaintiffs claimed using J&J talcum powder that contained asbestos caused ovarian cancer. Lawyers for the plaintiffs established that J&J knew the powder contained asbestos but denied that fact publicly. The judgment follows multiple other settlements and awards to plaintiffs including a $4.7 billion judgment by Missouri court in 2018.

[Read more here]

Robert O’Leary, JD BARA, has had an abiding interest in alternative health products & modalities since the early 1970’s & he has seen how they have made people go from lacking health to vibrant health. He became an attorney, singer-songwriter, martial artist & father along the way and brings that experience to his practice as a BioAcoustic Soundhealth Practitioner, under the tutelage of the award-winning founder of BioAcoustic Biology, Sharry Edwards, whose Institute of BioAcoustic Biology has now been serving clients for 30 years with a non-invasive & safe integrative modality that supports the body’s ability to self-heal using the power of the human voice. Robert brings this modality to serve clients in Greater Springfield, Massachusetts and New England (USA) & “virtually” the world. He can also be reached at romayasoundhealthandbeauty@gmail.

Johnson & Johnson Must Pay $72M for Cancer-causing Talcum Powder

By Jonathan Stempel | Reuters


Johnson & Johnson (JNJ.N) was ordered by a Missouri state jury to pay $72 million of damages to the family of a woman whose death from ovarian cancer was linked to her use of the company’s talc-based Baby Powder and Shower to Shower for several decades.

In a verdict announced late Monday night, jurors in the circuit court of St. Louis awarded the family of Jacqueline Fox $10 million of actual damages and $62 million of punitive damages, according to the family’s lawyers and court records.

The verdict is the first by a U.S. jury to award damages over the claims, the lawyers said.

Johnson & Johnson faces claims that it, in an effort to boost sales, failed for decades to warn consumers that its talc-based products could cause cancer. About 1,000 cases have been filed in Missouri state court, and another 200 in New Jersey.

Fox, who lived in Birmingham, Alabama, claimed she used Baby Powder and Shower to Shower for feminine hygiene for more than 35 years before being diagnosed three years ago with ovarian cancer. She died in October at age 62.

Jurors found Johnson & Johnson liable for fraud, negligence and conspiracy, the family’s lawyers said. Deliberations lasted four hours, following a three-week trial.

Jere Beasley, a lawyer for Fox’s family, said Johnson & Johnson “knew as far back as the 1980s of the risk,” and yet resorted to “lying to the public, lying to the regulatory agencies.” He spoke on a conference call with journalists.

Carol Goodrich, a Johnson & Johnson spokeswoman, said: “We have no higher responsibility than the health and safety of consumers, and we are disappointed with the outcome of the trial. We sympathize with the plaintiff’s family but firmly believe the safety of cosmetic talc is supported by decades of scientific evidence.”

Trials in several other talc lawsuits have been set for later this year, according to Danielle Mason, who also represented Fox’s family at trial.

[Read more here]

Originally entitled: “J&J must pay $72 million for cancer death linked to talcum powder: lawyers”

Robert O'Leary 150x150Robert O’Leary, JD BARA, has had an abiding interest in alternative health products & modalities since the early 1970’s & he has seen how they have made people go from lacking health to vibrant health. He became an attorney, singer-songwriter, martial artist & father along the way and brings that experience to his practice as a BioAcoustic Soundhealth Practitioner, under the tutelage of the award-winning founder of BioAcoustic Biology, Sharry Edwards, whose Institute of BioAcoustic Biology has now been serving clients for 30 years with a non-invasive & safe integrative modality that supports the body’s ability to self-heal using the power of the human voice. Robert brings this modality to serve clients in Greater Springfield (MA), New England & “virtually” the world, with his website. He can also be reached at romayasoundhealthandbeauty@gmail.